On behalf of Dr. Christos Markopoulos, meeting chairman, we are pleased to invite you to the Expert PracticeSM in Breast Cancer meeting in Lisbon, Portugal, on 15 November 2008.

Moderators:
        Lee Lokey, MD
        Bojana Pajk, MD
Chair:
        Christos Markopoulos, MD
Faculty:
        Matti Aapro, MD
        Nadia Harbeck, MD
        Veronique Dieras, MD
        Alison Jones, MD

Friday, 14 November 2008
Afternoon/Early Evening Arrivals 20.00-22.30 Reception followed by Buffet Dinner
Saturday, 15 November 2008
08.00-09.00	Breakfast
09.00-09.15	Welcome, Introduction, and Demographics	Christos Markopoulos, MD Lee Lokey, MD Bojana Pajk, MD
Case #1
09.15-09.45	Choice of Adjuvant Endocrine Therapy for a Postmenopausal Patient at Intermediate Risk of Recurrence	Nadia Harbeck, MD
Case #2
09.45-10.15	Locally Advanced Primary Breast Cancer: Multidisciplinary Management	Part I: Matti Aapro, MD Parts II & III: Christos Markopoulos, MD
Case #3
10.15-10.45	Metastatic Breast Cancer Following Adjuvant Anthracycline and Taxane: Best Choice of Therapy	Alison Jones, MD
10.45-11.15	Break
Case #4
11.15-11.45	Adjuvant Endocrine Therapy for a Perimenopausal Patient: What’s Best?	Nadia Harbeck, MD
Case #5
11.45-12.15	Management of Metastatic Breast Cancer in the Elderly Patient: A Unique Therapeutic Challenge	Matti Aapro, MD
12.15-12.45	Ask the Experts: An Interactive Discussion
12.45-13.45	Lunch
Case #6
13.45-14.15	Triple Negative Breast Cancer: Is There an Optimal Strategy?	Veronique Dieras, MD
Case #7
14.15-14.45	Endocrine Responsive Node Negative Breast Cancer in a Premenopausal Patient: Risk Assessment and Treatment Planning	Christos Markopoulos, MD
Interactive Debate
14.45-15.15	Optimal Treatment of Recurrent HER-2 Amplified Breast Cancer (One Year Following Completion of Adjuvant Trastuzumab) Should Be Rechallenge with Trastuzumab-based Therapy.	Pro: Alison Jones, MD Contra: Veronique Dieras, MD
15.15-15.30	Ask the Experts: An Interactive Discussion
15.30	Concluding Remarks	Christos Markopoulos, MD